A Study of the Efficacy and Safety of Topiramate as Add-on Therapy in the Treatment of Epilepsy Patients With Difficult to Treat, Partial-Onset Seizures.
This study has been completed.
Study NCT00236691
Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
First Received: October 7, 2005
Last Updated: October 19, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
